BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9457038)

  • 1. Leiomyosarcoma: a 45-year review at Charity Hospital, New Orleans.
    Hill MA; Mera R; Levine EA
    Am Surg; 1998 Jan; 64(1):53-60; discussion 60-1. PubMed ID: 9457038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location.
    Perez EA; Gutierrez JC; Moffat FL; Franceschi D; Livingstone AS; Spector SA; Levi JU; Sleeman D; Koniaris LG
    Ann Surg Oncol; 2007 Mar; 14(3):1114-22. PubMed ID: 17206483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases.
    Massi D; Beltrami G; Mela MM; Pertici M; Capanna R; Franchi A
    Eur J Surg Oncol; 2004 Jun; 30(5):565-72. PubMed ID: 15135488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group.
    Svarvar C; Böhling T; Berlin O; Gustafson P; Follerås G; Bjerkehagen B; Domanski HA; Sundby Hall K; Tukiainen E; Blomqvist C;
    Cancer; 2007 Jan; 109(2):282-91. PubMed ID: 17154171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroperitoneal soft-tissue sarcomas: prognosis and treatment of primary and recurrent disease.
    Bautista N; Su W; O'Connell TX
    Am Surg; 2000 Sep; 66(9):832-6. PubMed ID: 10993610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for soft-tissue sarcoma in 8249 cases from a large state cancer registry.
    Gutierrez JC; Perez EA; Franceschi D; Moffat FL; Livingstone AS; Koniaris LG
    J Surg Res; 2007 Jul; 141(1):105-14. PubMed ID: 17512548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
    Weitz J; Antonescu CR; Brennan MF
    J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
    Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.
    Smith R; Pak Y; Kraybill W; Kane JM
    Eur J Surg Oncol; 2009 Apr; 35(4):356-61. PubMed ID: 18294807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary gastrointestinal sarcomas.
    Medina-Franco H; Eltoum IE; Urist MM; Heslin MJ
    Am Surg; 2000 Dec; 66(12):1171-5. PubMed ID: 11149593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
    Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
    Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma.
    Wu TI; Chang TC; Hsueh S; Hsu KH; Chou HH; Huang HJ; Lai CH
    Gynecol Oncol; 2006 Jan; 100(1):166-72. PubMed ID: 16182349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary retroperitoneal tumors. Treatment modality and prognostic factors].
    Boneschi M; Erba M; Cusmai F; Eusebio D; Miani S; Bortolani EM
    Minerva Chir; 1999 Nov; 54(11):763-8. PubMed ID: 10638149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
    Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
    J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.
    Giuntoli RL; Garrett-Mayer E; Bristow RE; Gostout BS
    Gynecol Oncol; 2007 Jul; 106(1):82-8. PubMed ID: 17434579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroperitoneal leiomyosarcomas unassociated with the gastrointestinal tract: a clinicopathologic analysis of 17 cases.
    Rajani B; Smith TA; Reith JD; Goldblum JR
    Mod Pathol; 1999 Jan; 12(1):21-8. PubMed ID: 9950158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments.
    Chauveinc L; Deniaud E; Plancher C; Sastre X; Amsani F; de la Rochefordiere A; Rozemberg H; Clough KB
    Gynecol Oncol; 1999 Feb; 72(2):232-7. PubMed ID: 10021306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognosticators and the role of lymphadenectomy in uterine leiomyosarcomas.
    Ayhan A; Aksan G; Gultekin M; Esin S; Himmetoglu C; Dursun P; Usubutun A; Yuce K
    Arch Gynecol Obstet; 2009 Jul; 280(1):79-85. PubMed ID: 19096861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.